(Q43032645)

12 November 2017

Hepatitis C virus reinfection in injection drug users (English)

1 reference

12 November 2017

1 reference

1 reference

5

Mel Krajden

1 reference

12 November 2017

1

Jason Grebely

1 reference

12 November 2017

Brian Conway

2

1 reference

12 November 2017

Jesse D Raffa

series ordinal

3

1 reference

12 November 2017

Calvin Lai

series ordinal

4

1 reference

12 November 2017

Mark W Tyndall

series ordinal

6

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 November 2006

1 reference

12 November 2017

1 reference

12 November 2017

44

1 reference

12 November 2017

1139-1145

1 reference

12 November 2017

5

1 reference

Global epidemiology of hepatitis C virus infection

12 November 2017

1 reference

7 January 2021

Maximum impact of HIV prevention measures targeted at injecting drug users.

1 reference

7 January 2021

Correlates of hepatitis C virus infections among injection drug users.

1 reference

7 January 2021

Natural history of hepatitis C

1 reference

7 January 2021

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

7 January 2021

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

7 January 2021

Management and treatment of injection drug users with hepatitis C virus (HCV) infection and HCV/human immunodeficiency virus coinfection

1 reference

7 January 2021

Two successive hepatitis C virus infections in an intravenous drug user

1 reference

7 January 2021

Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children

1 reference

7 January 2021

Hepatitis C reinfection after liver transplantation in relation to virus genotype

1 reference

7 January 2021

Lack of Protective Immunity Against Reinfection with Hepatitis C Virus

1 reference

7 January 2021

Kinetics of CD4+ and CD8+ Memory T-Cell Responses during Hepatitis C Virus Rechallenge of Previously Recovered Chimpanzees

1 reference

7 January 2021

Cross-genotype immunity to hepatitis C virus

1 reference

7 January 2021

Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection

1 reference

7 January 2021

Immunity in chimpanzees chronically infected with hepatitis C virus: role of minor quasispecies in reinfection

1 reference

7 January 2021

Protection against persistence of hepatitis C.

1 reference

7 January 2021

HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help

1 reference

7 January 2021

Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection

1 reference

7 January 2021

Viral evolution of hepatitis C in injection drug users

1 reference

7 January 2021

Racial differences in HLA class II associations with hepatitis C virus outcomes

1 reference

7 January 2021

HLA-Cw*04 and hepatitis C virus persistence

1 reference

7 January 2021

HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection

1 reference

7 January 2021

Infrequent reinfection after successful treatment for hepatitis C virus infection in injection drug users

1 reference

7 January 2021

Follow-up studies of treatment for hepatitis C virus infection among injection drug users

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21376

1 reference

12 November 2017

1 reference